LEADER 02370nam 2200373 n 450 001 996391459303316 005 20200824121742.0 035 $a(CKB)4940000000106717 035 $a(EEBO)2240861748 035 $a(UnM)99860350e 035 $a(UnM)99860350 035 $a(EXLCZ)994940000000106717 100 $a19850829d1642 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe Queens Majesties message and letter from the Hague in Holland, directed to the Kings most excellent Majesty, &c$b[electronic resource] $ebeing sent in that ship which was forced to put in at Yarmouth by reason of a leake which she sprung at sea, and was bound for Newcastle, who had in her fifty commanders, besides other common souldiers, 400. barrels of powder, ten peeces of ordnance, and great store of other armes and ammunition, all which was sent to his Majesty. And now comming up to London to be disposed of by the Parliament for the kingdomes safety and security, which letter, with divers others, are in the custody of - Henry Elsing Cler. P. Dom. Com. All which letters were cast over-board into the sea, and miraculously saved by a sailor in the said ship. Also the declaration and petition of the Palsgrave and the Queene his mother to both houses of Parliament for their annuall pension, with all denying and disclaiming in having any hand or consent in Prince Roberts unruly actions, against the Parliament 210 $aLondon $cprinted for I. Vnderhill$dOctob. 14. [1642] 215 $a[2], 8 [i.e. 6] p 300 $aYear of publication from Thomason Coll. 300 $aPage 6 has been misnumbered 8. 300 $aReproduction of the original in the British Library. 330 $aeebo-0018 607 $aGreat Britain$xHistory$yCivil War, 1642-1649$vSources$vEarly works to 1800 700 $aHenrietta Maria$cQueen, consort of Charles I, King of England,$f1609-1669.$01002245 701 $aKarl Ludwig$cElector Palatine,$f1617-1680.$01002246 701 $aElizabeth$cQueen, consort of Frederick I, King of Bohemia,$f1596-1662.$01002247 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996391459303316 996 $aThe Queens Majesties message and letter from the Hague in Holland, directed to the Kings most excellent Majesty, &c$92300287 997 $aUNISA LEADER 02959nam 2200637Ia 450 001 9910791924303321 005 20230802012644.0 010 $a1-283-57735-6 010 $a9786613889805 010 $a0-19-978037-4 035 $a(CKB)2560000000089275 035 $a(EBL)995859 035 $a(OCoLC)806039918 035 $a(SSID)ssj0000704822 035 $a(PQKBManifestationID)12329285 035 $a(PQKBTitleCode)TC0000704822 035 $a(PQKBWorkID)10719611 035 $a(PQKB)11752415 035 $a(MiAaPQ)EBC995859 035 $a(Au-PeEL)EBL995859 035 $a(CaPaEBR)ebr10589616 035 $a(CaONFJC)MIL388980 035 $a(EXLCZ)992560000000089275 100 $a20120903d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDyslipidemia$b[electronic resource] /$fRagavendra R. Baliga, Christopher P. Cannon 210 $aOxford ;$aNew York $cOxford University Press$d2012 215 $a1 online resource (152 p.) 225 1 $aOxford American Cardiology Library 300 $aDescription based upon print version of record. 311 $a0-19-974286-3 320 $aIncludes bibliographical references and index. 327 $aCover; Contents; Contributors; 1 LDL Cholesterol; 2 HDL Cholesterol; 3 Non-HDL Cholesterol; 4 Use of High Sensitivity C-Reactive Protein for Risk Assessment; 5 Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6 Stratification of Dyslipidemic Risk; 7 Drugs for Treatment of Blood Lipoprotein Abnormalities; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; V; W; X; Z 330 $aDyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control 410 0$aOxford American Cardiology Library 606 $aLipids$xMetabolism$xDisorders$xTreatment 606 $aAtherosclerosis$xTreatment 606 $aCoronary heart disease 615 0$aLipids$xMetabolism$xDisorders$xTreatment. 615 0$aAtherosclerosis$xTreatment. 615 0$aCoronary heart disease. 676 $a616.3/997 676 $a616.3997 701 $aBaliga$b R. R$01484997 701 $aCannon$b Christopher P$0893564 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910791924303321 996 $aDyslipidemia$93756916 997 $aUNINA